These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28046035)

  • 1. Development of the Liverpool Adverse Drug Reaction Avoidability Assessment Tool.
    Bracken LE; Nunn AJ; Kirkham JJ; Peak M; Arnott J; Smyth RL; Pirmohamed M; Turner MA
    PLoS One; 2017; 12(1):e0169393. PubMed ID: 28046035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation into the avoidability of adverse drug reactions using the LAAT and modified Hallas tools.
    Danjuma MI; Shokri SA; Abubeker IY; Malik AE; Abdallah IMH; Shafei MNE; Fatima H; Mahmoud M; Hussain T; Maghoub Y; Sajid J; Zouki ANE
    Medicine (Baltimore); 2020 Jan; 99(1):e18569. PubMed ID: 31895800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAEDIATRIC ADVERSE DRUG REACTIONS (ADRS): A COMPARISON OF A NEWLY DEVELOPED AVOIDABILITY TOOL TO EXISTING HALLAS ASSESSMENTS.
    Bracken L; Kirkham J; Nunn A; Pirmohamed M; Peak M; Turner M
    Arch Dis Child; 2016 Sep; 101(9):e2. PubMed ID: 27540256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool.
    Gallagher RM; Kirkham JJ; Mason JR; Bird KA; Williamson PR; Nunn AJ; Turner MA; Smyth RL; Pirmohamed M
    PLoS One; 2011; 6(12):e28096. PubMed ID: 22194808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avoidability of drug-induced liver injury (DILI) in an elderly hospital cohort with cases assessed for causality by the updated RUCAM score.
    Danjuma MI; Almasri H; Alshokri S; Khir FK; Elmalik A; Battikh NG; Abdallah IMH; Elshafei M; Fatima H; Mohamed MFH; Maghoub Y; Hussain T; Kamal I; Anwer Z; Bidmos MA; Elzouki AN
    BMC Geriatr; 2020 Sep; 20(1):346. PubMed ID: 32928134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translation, transcultural adaptation and validation to Brazilian Portuguese of tools for adverse drug reaction assessment in children.
    da Costa Lima E; de Barros Fernandes T; Freitas A; de Lima Sias JF; Land MGP; Aires MT; Bracken L; Peak M
    BMC Med Res Methodol; 2021 Jul; 21(1):141. PubMed ID: 34238235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Liverpool Causality Assessment Tool vs. the Naranjo Scale for predicting the likelihood of an adverse drug reaction: A retrospective cohort study.
    Um SH; Abuzgaia A; Rieder M
    Br J Clin Pharmacol; 2023 Aug; 89(8):2407-2412. PubMed ID: 36849649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interrater agreement of two adverse drug reaction causality assessment methods: A randomised comparison of the Liverpool Adverse Drug Reaction Causality Assessment Tool and the World Health Organization-Uppsala Monitoring Centre system.
    Mouton JP; Mehta U; Rossiter DP; Maartens G; Cohen K
    PLoS One; 2017; 12(2):e0172830. PubMed ID: 28235001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective identification and causality evaluation of suspected adverse drug reactions in neonates.
    Roberts EK; Hawcutt DB; Turner MA
    Br J Clin Pharmacol; 2021 Mar; 87(3):1541-1546. PubMed ID: 32696451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of three pharmacovigilance algorithms in the ICU setting: a retrospective and prospective evaluation of ADRs.
    Kane-Gill SL; Forsberg EA; Verrico MM; Handler SM
    Drug Saf; 2012 Aug; 35(8):645-53. PubMed ID: 22720659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients.
    Franceschi M; Scarcelli C; Niro V; Seripa D; Pazienza AM; Pepe G; Colusso AM; Pacilli L; Pilotto A
    Drug Saf; 2008; 31(6):545-56. PubMed ID: 18484788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tailor-made approach for causality assessment for ADR reports on drugs and vaccines.
    Oosterhuis I; Zweers P; Rümke H; Muller-Hansma A; van Puijenbroek EP
    Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):544-550. PubMed ID: 30168222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of a new instrument for detecting preventable adverse drug reactions.
    Benkirane R; Soulaymani-Bencheikh R; Khattabi A; Benabdallah G; Alj L; Sefiani H; Hedna K; Ouammi L; Olsson S; Pal SN
    Drug Saf; 2015 Apr; 38(4):383-93. PubMed ID: 25537235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A targeted method for standardized assessment of adverse drug events in surgical patients.
    de Boer M; Kiewiet JJ; Boeker EB; Ramrattan MA; Dijkgraaf MG; Lie-A-Huen L; Boermeester MA;
    J Eval Clin Pract; 2013 Dec; 19(6):1073-82. PubMed ID: 23593984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and application of Adverse drug reactions reports QUality Algorithm (AQUA-12) score: a single-centre quality improvement initiative.
    Aung AK; Zubrinich CM; Goh MSY; Snyder B; Tang MJ; Khu CYL; Lee JI; Graudins LV
    Eur J Clin Pharmacol; 2023 Apr; 79(4):513-522. PubMed ID: 36806970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causality assessment of adverse drug reactions in neonates: a comparative study between Naranjo's algorithm and Du's tool.
    Leopoldino RWD; de Oliveira LVS; Fernandes FEM; de Lima Costa HTM; Vale LMP; Oliveira AG; Martins RR
    Int J Clin Pharm; 2023 Aug; 45(4):1007-1013. PubMed ID: 37212967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial development and testing of an instrument for patient self-assessment of adverse drug reactions.
    Jarernsiripornkul N; Chaipichit N; Pratipanawatr T; Uchaipichat V; Krska J
    Pharmacoepidemiol Drug Saf; 2016 Jan; 25(1):54-63. PubMed ID: 26349635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of WHO-UMC and Naranjo Scales for Causality Assessment of Reported Adverse Drug Reactions.
    Pandit S; Soni D; Krishnamurthy B; Belhekar MN
    J Patient Saf; 2024 Jun; 20(4):236-239. PubMed ID: 38345209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug reactions in hospital in-patients: a pilot study.
    Davies EC; Green CF; Mottram DR; Pirmohamed M
    J Clin Pharm Ther; 2006 Aug; 31(4):335-41. PubMed ID: 16882102
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.